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Thromboembolic complications rarely occur in fetuses and newborns, suggesting that protective mechanisms are in place in the young. Biologically, the ability to regulate thrombin formation and activity are of central importance to the prevention and formation of large-vessel thrombi. Regulation of thrombin under physiologic circumstances involves both plasma coagulation and inhibitors, as well as interactions with endothelial cell surfaces (1) . Under physiologic conditions, endothelial cells present an anticoagulant surface that maintains vessel wall thromboresistance (2) .
There are age-dependent differences in the regulation of thrombin that may, in part, explain the low rates of thrombotic complications in the young. Decreased amounts of thrombin are generated in cord plasmas compared with adult plasmas, reflecting low plasma concentrations of prothrombin in cord plasmas (3) . In addition, a2M is as important an inhibitor of thrombin as ATIII in fetal plasma (4) . Consequently, the antithrombin effect of a,M may remain significant throughout ' Holder of a Fellowship from the Heart and Stroke Foundation.
childhood, inasmuch as it is elevated above adult levels until A Career Scietist of the Heart and Stroke Foundation.
after adolescence (5) . However, these previous studies of 374 LING ET AL. Figure 1 . Comparison of prothrombin consumption and free thrombin activities in adult plasma (0) and cord plasma (@) in the presence of a plastic surface after activation with coagulant phospholipids. The data are presented in nM as means 2 2 SEM of at least five experiments.
TIME (mln)
thrombin regulation in cord plasmas were conducted in the presence of plastic surfaces (3, 4) . No previous studies have evaluated endothelial cell-surface regulation of thrombin formation or inhibition in a fetal system, even though this is known to be very important in the mature adult system. Therefore, the overall objective of this study was to explore ontogenic influences on thrombin regulation in the presence of endothelial cell surfaces. TIME (mln) Figure 2 . Comparison of prothrombin consumption and free IIa activities in adult plasma (0) and cord plasma (@) in the presence of a human endothelial cell surface after activation with coagulant phospholipids. The data are presented in nM as means 2 2 SEM of at least five experiments. man @ro)thrombin antibody was produced as described previously (6), and rabbit antihuman prothrombin antibody was from Behring Corporation (Montreal, Quebec, Canada). Goat antirabbit IgG-alkaline phosphatase-conjugated antibody was purchased from Dimension Laboratories (Toronto, Ontario, Canada). Arvin (ancrod) was obtained from Connaught Laboratories Ltd. (Toronto, Ontario, Canada), and goat antihuman
METHODS

Materials.
Fetal bovine serum, M-199 media, penicillinstreptomycin, L-glutamine and trypsin-EDTA (0.05% trypsin and 0.53 mM EDTA) were purchased from GIBCO Laboratories (Grand Island, NY); tissue culture flasks (25 X 25 cm) were from Becton Dickinson (Lincoln Park, NJ; 24-well plates were purchased from Nunc (Roskilde, Denmark); collagenase and p-nitrophenyl phosphate were from Sigma Chemical Co. 
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heparin cofactor I1 antibody was purchased from Behring Hoechst (Montreal, Quebec, Canada). Human HCII was purified from plasma using the method of Griffith et al. (7) . Dermatan sulfate was obtained from Mediolanum (Milan, Italy 1-Collection and preparation of plasma samples. Cord blood was obtained immediately after deliveries by withdrawing blood from double-clamped umbilical cords. All deliveries were uneventful full-term deliveries (37-41 wk gestational age) with appropriate birth weight and Apgar scores. Adult blood samples were obtained from 20 healthy donors and were similarly anticoagulated. Cord plasmas were pooled (five cords per pool), and plasmas from 20 adult donors were pooled. Analysis of adult and cord plasma pools for IIa-inhibitor complexes (IIa-ATIII, IIa-a2M, and IIa-HCII analyzed as described below) showed that levels were less than 2 nM in each case. Therefore, activation of coagulation, as measured by thrombin-inhibitor complex formation, was minimal during plasma collection and preparation in relation to that during thrombin generation.
Human umbilical endothelial cell culture. Endothelial cells were isolated from HUVEC using 0.06% collagenase by a technique described by Jaffe et al. (8) . HUVEC were maintained in M-199 media supplemented with 20% (vol/vol) fetal bovine serum, penicillin (100 UImL), streptomycin (100 pg/ mL), and 2 nM L-glutamine in flasks (25 X 25 cm) at 37OC in a 5% CO, atmosphere. Subculturing into 24-well plates was performed by treating confluent monolayers with trypsin-EDTA (0.05% trypsin and 0.53 mM EDTA) after growing for 5 d in the flasks. Cells were plated into 24-well plates at a density of 8 X 10' to 1 X lo6 cells per well and cultured using the same media conditions as with flasks. Confluent monolayers of cells passed only once into 24-well plates were used for experiments within 48-72 h after plating. Endothelial cells were identified by their morphology and by indirect immunofluorescence for Von Willebrand factor (9) .
Thrombin generation and prothrombin consumption. Total amidolytic thrombin activity on cell surfaces or plastic surfaces wa$ quantitated by previously described procedures (10, 11). Cell monolayers were washed twice with 1 mL of acetatebarbital-buffered saline, pH 7.4 (0.036 M sodium acetate, 0.036 M sodium diethylbarbitarate, and 0.145 M sodium Chloride). After this, 200 p L of defibrinated plasma was incubated for 3 min with endothelial monolayers and 100 pL of either platelin (coagulant phospholipids) or 10% APTT reagent. Calcium chloride (100 p L of 0.04 M CaCI, in buffered saline) was then added. At timed intervals (1-16 min) after the addition of calcium chloride, 25-pL aliquots were removed from the wells. Each aliquot was mixed with 475 p L of 0.005 M EDTA at 4OC. A 25-pL aliquot of each time sample-EDTA mixture was immediately added to 75 pL of 0.16 mM S-2238 in buffered saline and maintained at 37OC for 10 min. Amidolysis of S-2238 was then stopped by addition of 200 p L of 50% acetic acid, and absorbance at 405 nm was determined. A standard curve was generated using increasing concentrations of purified human thrombin. Based on known concentrations of purified thrombin in acetate-barbital buffered saline, an absorbance of 1.0 represented 1796 nM of thrombin in defibrinated plasma.
Thrombin bound to a,M retains amidolytic activity against S-2238 (12), thereby contributing to the total amidolytic activity measured in thrombin generation experiments. Therefore, free IIa activity was determined as described previously (1 1). Briefly, the amidolytic activity of thrombin-a,M complex was determined [by measuring residual activity with S-2238 after neutralization of free IIa with a large excess of ATIII (12Ul mL) and heparin (71U/mL), followed by addition to EDTA (0.005 M)] and subtracted from the total amidolytic thrombin activity measured as described above. Prothrombin concentrations were measured by ELISA in the EDTA aliquot used for quantitating thrombin activity (6) . Thrombin-AT111 and thrombin-HCII were also measured by ELISA (Affinity Biologicals, Yarker, Ontario, Canada).
Statistical analysis. All results are expressed as mean values of at least five experiments ? 2 SEM. An unpaired r test was used to compare differences in thrombin generation between adult and cord plasmas after activation with either coagulant phospholipids or 10% APTT reagent. p < 0.05 were considered significant. To further assess the difference between adult versus cord plasma, a one-way analysis of variance was used.
RESULTS
Prothrombin consumption and thrombin generation on plastic or HUVEC surfaces after exposure to 10% APTT reagent. Prothrombin consumption and IIa activity were measured in adult and cord plasmas in the presence of plastic or HUVEC surfaces after exposure to 10% AP'IT reagent (a relatively strong stimulus). On either plastic or HUVEC, in adult plasma or in cord plasma, approximately 90% of the starting prothrombin concentrations were consumed by 2 min. Coincidentally, on either plastic or HUVEC, a peak of thrombin activity appeared in either adult plasma (632 + 59 nM at 2.5 rnin on plastic and 643 + 13 nM at 2.5 rnin on HUVEC) or in cord plasma (408 + 30 nM at 2 rnin on plastic and 389
Ifr 23 nM at 2 rnin on HUVEC). Therefore, with a strong stimulus, prothrombin was nearly completely consumed and maximal thrombin generated within a short period of time, regardless of surface or plasma. Thus, the fact that more thrombin was generated in adult plasma compared with cord plasma, on either surface, likely reflected the higher prothrombin concentrations in adult plasma than in cord plasma (1006 ? 114 nM and 527 + 42 nM for adult and cord, respectively).
Prothrombin consumption and thrombin generation on plastic or endothelial cell surfaces after exposure to coagulant phospholipids. Prothrombin consumption and IIa activity were compared in adult and cord plasmas in the presence of plastic or HUVEC surfaces after exposure to coagulant phospholipids (a relatively weak stimulus that may simulate in vivo conditions). On plastic, greater than 90% of starting prothrombin concentrations were consumed in both adult and cord plasmas by 6 rnin (Fig. 1, upper panel) whereas detectable IIa activities were significant, maximally at 5-6 rnin (Fig. 1, lower  panel) . However, on HUVEC, in both adult and cord plasmas, only 50% of starting prothrombin concentrations were con-376 LING ET AL.
sumed by 16 min (Fig. 2, upperpanel) . Detectable IIa activity was minimal relative to plastic, appearing at more than 4 min in both plasmas on HUVEC (Fig. 2, lower panel) .
Thrombin inhibitor complex formation. To explore potential mechanisms responsible for differences in regulation of thrombin generation and inhibition in adult and cord plasmas, because of HUVEC surface, thrombin-inhibitor complexes were measured. After exposure to 10% AP?T reagent, total plasma concentrations of thrombin-inhibitor complexes in adult plasma were significantly greater than in cord plasma on plastic or HUVEC (Tables 1 and 2 ). ATIII remained the major inhibitor of thrombin in adult plasma, whereas a2M remained as important as ATIII in cord plasma (Tables 1 and 2) .
After exposure to coagulant phospholipids, total plasma concentrations of thrombin-inhibitor complexes in adult plasma were significantly greater than in cord plasma on a plastic surface (Table 1 ). In contrast, interaction of plasma with coagulant phospholipids on an HUVEC surface resulted in similar total concentrations of thrombin-inhibitor complexes in adult and cord plasmas ( Table 2) . On both surfaces, ATIII was the major inhibitor of thrombin in adult plasma, whereas a2M was at least as important as ATIII in cord plasma (Tables 1 and  2 ).
These data suggested that low plasma concentrations of ATIII in cord plasma may limit the ability of any HUVECsurface heparan sulfate to potentiate the inhibition of thrombin by ATIII, especially in the case of a strong stimulus. To test this hypothesis, cord plasma was supplemented with purified ATIII and thrombin-generation experiments repeated in the presence of HUVEC surfaces.
Effect of ATZZZ supplementation of cord plasma on prothrombin consumption and thrombin generation on HUVEC surfaces. It has been shown that plasma ATIII levels in the fetus at full term are lower than in adults [60% of adult values (13)l. Purified human ATIII (0.55 UImL) was added to cordpooled plasma to increase the final concentration to a measured value of 1.1 U/mL and experiments repeated in response to coagulant phospholipids and 10% APTT reagent. After either stimuli, prothrombin consumption was similar in cord plasma plus ATIII compared with cord plasma (Fig. 3) . However, the amount of thrombin activity measured was significantly decreased in cord plasma plus ATIII compared with cord plasma (Fig. 3) . Effect of ATZZZ supplementation of cord plasma on thrombin-inhibitor complex formation. Thrombin-inhibitor complexes were measured in these same experiments. After exposure to coagulant phospholipids, total plasma concentrations of thrombin-inhibitor complexes were similar in cord plasma plus ATIII and cord plasma. a2M remained as important as ATIII for the inhibition of thrombin in the presence of plasma supplementation with ATIII (Table 2) . After exposure to 10% APTT reagent, total plasma concentrations of thrombininhibitor complexes were similar in cord plasma plus ATIII and cord plasma. However, ATIII was now significantly more important than a2M for the inhibition of thrombin (Table 2) .
DISCUSSION
Although endothelial cell-surface anticoagulant properties have been characterized in the presence of the adult coagulation system (1, 11, 14) , there are no previous studies assessing a developmentally immature hemostatic system. Our study addressed this question and showed that endothelial cell surfaces regulated prothrombin consumption and thrombin generation in a fetal system, with a pattern similar to that in the mature adult system. After exposure to a strong stimulus (10% APlT), all prothrombin was consumed, regardless of plasma, resulting in more IIa and a higher proportion of thrombin-ATIII than thrombin-a2M in adult plasma than in cord plasma. This result may have been predicted, given the higher starting prothrombin concentration (stated above) and the higher AT111 concentration (1 and 0.6 for adult and cord, respectively) in adult plasma. However, with a mild stimulus (coagulant phospholipids), total prothrombin consumption on an HUVEC surface was limited to 50% of starting concentrations in either adult or cord plasmas compared with more than 90% consumption in the absence of cells. Also, with the mild stimulus, less thrombin was generated in the fetal system, and a2M, not ATIII, was the major inhibitor of thrombin. The latter observations reflected the decreased plasma concentration of prothrombin (3, 4) , increased concentration of a2M, and decreased levels of ATIII in the fetal system [48, 139, and 63% of adult levels, respectively (13)l. 
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Under physiologic circumstances, endothelial cell surfaces regulate thrombin activity through several mechanisms. First, endothelial cells synthesize and secrete glycosaminoglycans, including heparan sulfate (15) (16) (17) . Both in virro studies and in vivo studies in rats have clearly shown that endothelial cellsurface heparan sulfate catalyzes thrombin inhibition by ATIII (16, 17) . Second, a specific endothelial cell-surface thrombin receptor, thrombomodulin, complexes thrombin, thereby altering its substrate specificity (18) . Thrombin complexed to thrombomodulin no longer functions as a coagulant by cleaving fibrinogen and activating FV and FVIII (19) ; it functions as an inhibitor of coagulation by activating the protein Clprotein S inhibitory system (20, 21) . Activated protein C downregulates thrombin generation by limited proteolysis of FVa and FVIIIa (22) . Third, endothelial cells decrease thrombin generation by receptor-mediated endocytosis and degradation of factor Xa (23, 24) .
There are several reasons for suspecting that endothelial cell-surface regulation of thrombin may differ in fetal plasma than in adult plasma. First, fetal plasma concentrations of the thrombin inhibitors ATIII and HCII are approximately 50% of adult values (3, 25, 26) . Therefore, catalysis of ATIII and HCII inhibition of thrombin activity by endothelial cell-surface glycosaminoglycans may not be as efficient in fetal than in adult plasma. Second, plasma concentrations of prothrombin are only 50% of adult values, causing less thrombin to be generated in the presence of a plastic surface (Fig. 1, lower panel) . Third, an anticoagulant with characteristics of dermatan sulfate is present in maternal and fetal plasma (27) . Dermatan sulfate catalyzes the inhibition of thrombin by HCII and acts synergistically with heparin to inhibit thrombin (28). Fourth, in contrast to ATIII and HCII, newborn plasma concentrations of a2M are increased compared with adult values (13) . Our results show that a2M inhibits as much thrombin as ATIII in fetal plasma in the presence of plastic or HUVEC, which agrees with the fact that thrombin-a2M complexes are present in plasma from sick newborns (29). Fifth, activated protein C activity in fetal plasma is decreased, reflecting protein C levels less than 50% of adult values, and potentially a fetal form of protein C (30).
In this study, the effect of endothelial cell-surface regulation of thrombin was compared in adult and fetal systems after exposure to either a weak (coagulant phospholipids) or a strong activator (10% APTT reagent). The weak activator likely simulates in vivo conditions more closely than the strong activator. The pattern of response was similar in cord and adult plasma for both activators. On an HUVEC surface, after the weak activator, decreased amounts of prothrombin were consumed compared with plastic surface and less IIa generated compared with the stronger activator. However, the magnitude of the response differed significantly in adult and fetal plasmas. Initial prothrombin concentrations were decreased in fetal plasma compared with adult plasma, resulting in decreased absolute amounts of prothrombin consumed and thrombin generated, as has been shown previously on plastic surfaces (3). ATIII was the major inhibitor of thrombin in adult plasma. However, a2M was as important as ATIII in fetal plasma.
Together, these observations suggested that endothelial cellsurface heparan sulfate catalysis of ATIII inhibition of thrombin was impaired in fetal plasma because of low concentrations of ATIII. This hypothesis was tested by supplementing fetal plasma with purified ATIII and thrombin generation experiments repeated in the presence of endothelial cell surfaces. After either the weak or strong activator, similar amounts of prothrombin were consumed but less thrombin generated in ATIII-supplemented fetal plasma than in unsupplemented plasma. Although the amounts of thrombin inhibitor complexes generated were similar, ATIII, not a2M, was the predominant inhibitor of thrombin in ATIII-supplemented plasma after the strong activator.
Our findings provide insight into potential mechanisms that protect healthy newborns from thrombotic complications, despite their low plasma concentration of ATIII. The decreased capacity to generate thrombin may slow the formation of fibrin after a pathologic stimulus. This was illustrated in experiments on HUVEC using 10% APTT and cord plasma, supplemented with prothrombin to adult levels, in which IIa generated and prothrombin consumed approached that of adult plasma (n = 3; data not shown). Also, increased plasma concentrations of a2M compensate for low levels of ATIII and contribute significantly to the inhibition of thrombin, even in the presence of endothelial cell surfaces. Although not widely appreciated, a2M is present on the luminal surface of endothelial cells in normal human arteries, veins, and lymphatics (31) . Whether endothelial cells interact with a,M, thereby influencing thrombin regulation by this inhibitor, remains to be determined (31,\
3L).
The results of this study are also relevant to the treatment of RDS in newborns. RDS is characterized by fibrin deposition in the lung, intravascularly, extravascularly, and intraalveolarly (33, 34) . Plasma concentrations of ATIII are decreased even further in infants with RDS compared with their healthy counterparts (35) (36) (37) (38) . This observation has provided the rationale for previous and ongoing intervention studies in neonatal RDS with ATIII concentrates.
In summary, endothelial cell-surface regulation of thrombin differs in fetal and adult plasma. Decreased concentrations of prothrombin and ATIII and increased concentrations of a2M in fetal plasma provide at least part of the explanation for our findings. Future studies are needed to investigate the physiologic role of thrombomodulin, protein C, and protein S on thrombin regulation in fetal and adult systems.
